Download presentation
Presentation is loading. Please wait.
Published byDaniella Maxwell Modified over 9 years ago
1
Western Australia
2
AD Rate AD Changepoints Vaccines Paternal Age Thimerosal N/A Diagnostic Substitution N/A Polio N/A MMRVaricella Hep A Live Births Live Births vs AD WESTERN AUSTRALIA (Click on the graphs under each topic)
3
Go back to main pageData
4
Nassar N DG, Bourke J, Bower C, Glasson E, de Klerk N, Leonard H. (2009) Autism spectrum disorders in young children: effect of changes in diagnostic practices. Int J Epidemiol 38: 1245-1254. Graphs Go back to main page Birth Year Prevalence per 10,000 Live birthsAD cases 19830.834888230871.9 19842.171511216254.7 19850.785809231091.8 19861.233448242363.0 19870.348022233320.8 19881.573351251434.0 19891.187927250513.0 19902.302145253565.8 19913.694507254179.4 19925.9753972507315.0 19936.8120182508117.1 19947.9264182513819.9 199510.3741582513926.1 199613.0441212479332.3 199719.1584532477547.5 199818.8838662471746.7 199919.6650232484948.9
5
AD Changepoint 1983 – 1999, 2-3 year olds 1990.4 Go back to main page
6
MEASLES, MUMPS, RUBELLA, VARICELLA 1989MMR IICombined measles, mumps and rubella Merck, Sharp, Dohme - MSD >=12 monthsLicensed 7/1/2013MMRVCombined measles, mumps, rubella and varicella 1999Varivax Varicella virus vaccine, live Merck, Sharp, Dohme - MSD >=12 monthsLicensed 1999VarilrixGSK>=12 monthsLicensed 1990.4 MMR II Go back to main page
7
HEPATITIS A VACCINE HISTORY IN WESTERN AUSTRALIA N/A Avaxim The inactivated hepatitis A vaccine Sanofi Pasteur≥2 years N/A Havrix Junior GSK2–<16 N/A Havrix 1440 GSK>=16 years N/A Vaqta Paediatric CSL Limited/Merck & Co Inc 1–<18 years N/A Vaqta Adult formulation CSL Limited/Merck & Co Inc ≥18 years N/A Twinrix Junior Combined Hep A and B GSK1–<16 years N/A TwinrixGSK≥16 years N/A Vivaxim Combined Hep A and typhoid Sanofi Pasteur≥16 years All Hep A vaccines in Western Australia use MRC-5 human diploid cells Go back to main page
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.